Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NKarta Therapeutics Inc.

Latest From NKarta Therapeutics Inc.

Kiadis Buying CytoSen Will Combine Natural Killer And T-Cell Immunotherapies

An all-stock transaction will see Europe’s Kiadis and US’s CytoSen bring together complementary approaches to improving stem cell transplants and cancer immunotherapy.


M & A ImmunoOncology
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • NKarta Therapeutics Inc.
  • Senior Management
  • Paul Hastings, CEO
    Matthew Plunkett, PhD, SVP, CFO
    Angela SHen, MD, CMO
    Nadir Mahmood, PhD, SVP, Corp. Dev.
  • Contact Info
  • NKarta Therapeutics Inc.
    6000 Shoreline Ct.
    Ste. 102
    Suth San Francisco, CA 94080